Invesco Ltd. Forma Therapeutics Holdings, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $13,328 - $37,889	-1,872 Reduced 2.74%	66,396 $1.33 Million
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $57,221 - $112,200	11,220 Added 19.67%	68,268 $470,000
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $376,259 - $662,739	45,115 Added 378.07%	57,048 $531,000
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $26,615 - $48,709	-1,957 Reduced 14.09%	11,933 $170,000
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $31,893 - $38,627	1,503 Added 12.13%	13,890 $323,000
Q2 2021 Aug 17, 2021	BUY	$22.86 - $30.95 $283,166 - $383,377	12,387 New	12,387 $308,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.